Foghorn Therapeutics Inc

FHTX NASDAQ Santé & Biotech États-Unis US3441741077
3.69 $
1.60 %

Foghorn Therapeutics Inc développe des thérapies ciblées sur l'épigénétique pour combattre de graves maladies, notamment des cancers.

Performance & Momentum

6 Months 19.21 %
1 Year 11.90 %
3 Years 49.11 %
5 Years 64.96 %

Similar stocks to Foghorn Therapeutics Inc

Anantys Community

Be the first to share your analysis on Foghorn Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases